adrenal cortex. The external genital development in such cases was always female, and he suggested that there was an enzyme defect at an early stage of steroid synthesis both in the adrenal cortex and in the Leydig cells of the testis. Grumbach and Wilkins (1956) published a review of 55 cases, and noticed that, while the disease varied among families, within each family it appeared to follow the same clinical patter, i.e. salt-losers, hypertensives, etc. Childs, Grumbach, and Van Wyk (1956) estimated that the incidence of heterozygotes in the general population was 1 per 128; and Wilkins (1962) thought the incidence lay between 1: 50 and 1:100.
With regard to salt loss, Eberlein (1958) reported that infants with this type of congenital adrenal hyperplasia required more desoxycorticosterone acetate (DCA) than did adults with Addison's disease. Urinary aldosterone excretion was measured by Blizzard, Liddle, Migeon, and Wilkins (1959) in the simple virilizing type of congenital adrenal hyperplasia and they found normal levels of aldosterone. In the salt-losing types they found reduced levels.
This contasted with earlier work by Prader, Spahr, and Neher (1955) who found increased levels of aldosterone in patients with the salt-losing type of congenital adrenal hyperplasia.
Cortisol production rates have now been measured. Kenny, Malvaux, and Migeon (1963) found that in newborns the rates were similar to those in adults when the figures were corrected for surface area. Infants with the salt-losing type of congenital adrenal hyperplasia were found to have lower than normal production rates. Grumbach and Wilkins (1956) Cortioo (Hydrocortisone, cmpomxl F) . The understanding of the defects in congenital adrenal hyperplasia is best achieved by reviewing the metabolic pathway in the formation of cortisol. A simplified version is given in Fig. 1 . For the production of cortisol, three hydroxyl groups are added to progesterone by specific enzymes in a definite sequence. The numbers refer to the position on the steroid nucleus (Fig. 2) to be 1 1-deoxygenated. This forms the basis for the 11-oxygenation index as a test for diagnosis (Hill, 1960) . For the production of corticosterone and aldosterone, there is no initial C-17 hydroxylation, and these substances are not measured as 17-hydroxycorticoids. C-21 hydroxylation is the first step. This enzyme, therefore, is required both for the production of mineralocorticoid and of cortisol, and a deficiency of this enzyme has been postulated as an explanation for the salt-losing type of congenital adrenal hyperplasia. Indeed, Bongiovanni (1958) has suggested that the salt-losing type may merely represent a severer type of enzyme defect at this level For the production of corticosterone, C-11 hydroxylation is the next step, whereas for the formation of aldosterone, an aldehyde group is required at position C-18. RAITI AND NEWNS Adrenal steroid secretion rates in adults have been measured and are listed in Table 1 . In infants, figures for the cortisol production rates in newborn babies have been estimated, using radioisotope techniques (Kenny et al., 1963) . The mean production rate was found to be 3-1 mg. per 24 hours. When corrected for surface area, these figures are similar to those of adults. ..
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Peterson (1957) Explanation of Laboatory Terms (1) 1 7-ketosteroids (17-oxysteroids) are substances that have a ketone group ( 0) at position C-17 on the steroid nucleus. Though the estimation is nonspecific, it is helpful in controlling treatment. The value includes such derivatives as dehydroepiandrosterone, androsterone, and aetiocholanolone. In circumstances where the production of 17-hydroxypregnane derivatives is very high, the 17-ketosteroids will be raised due to the conversion of about 5-100% of 17-hydroxypregnane derivatives. Values obtained in normal children are set out in Table 2 (Prout and Snaith, 1958) . (2) Total 17-hydroxycorticoids are substances that have a hydroxyl group in the C-17 position. They include all the substances shown in Fig. 1 and exclude steroids from other sources such as the testis. They represent a more specific estimation of the metabolic products in the pathway for production of cortisol. Values obtained in normal children are set out in Table 3 .
(3) Pregnanetriol is an abnormal metabolite excreted in the urine of patients who have a block in 21-hydroxylation, and it can be measured. (5) l1-oxygenation index measures the ratio of substances without an oxygenation function at the C-1l position to those with such a function, i.e. cortisone and cortisol. The I 1-deoxygenated substances include 'compound S' and 1 7-x-hydroxyprogesterone and their abnormal metabolites (Hill, 1960) . Normally the ratio of 1 1-deoxygenated to I 1-oxygenated substances is 1 : 2 or less. If the ratio becomes reversed, i.e. 2 : 1 or greater, it indicates that there are more precursor substances than there is cortisol and that there must be an accumulation of substances that have not been hydroxylated at the C-Il position. It does not indicate whether the block is at C-l I or C-21. The advantage is that the test can be performed on a random sample of urine (Barratt, Edwards, Makin, and Clayton, 1964) .
(6) Two-dimensional paper chromatography can be used to obtain a qualitative indication of the type of enzymatic block present (Edwards, 1960 (Edwards, , 1961 (Edwards, , 1962 and in another in which there was a penile urethra. In the male patients, the genitalia appeared normal on admission, and pyloric stenosis was suspected in the first instance in 6 patients.
Initial investigations were carried out: 24 patients showed initial disturbances in serum electrolytes characterized by a low serum sodium and chloride and high serum potassium, i.e. an Addisonian picture. In 12 of these patients there was an initial raised blood urea which fell to normal limits following treatment. Urinary 17-ketosteroid levels were raised, values varying between 2-5 and 5-12 mg./24 hr. in 14 and 10 patients respectively (no figures were available for the remaining cases). Pregnanetriol was detected in the urine in amounts varying from 0 6-10 5 mg./24 hr., in the 13 patients in whom it was estimated. A buccal smear for nuclear sex was performed on 9 patients.
The initial diagnosis was made, therefore, on a history ofrecurrent vomiting (often projectile in type), refusal to feed, weight loss, abnormal genitalia (if female), an Addisonian type of disturbance of serum electrolytes, and raised 1 7-ketosteroid and pregnanetriol levels in the urine.
If the child was not dehydrated on admission, investigations were carried out first; if he or she was, therapy (see Table 5 ) was commenced forthwith. although it is now the practice to try to collect a 4-to 5-hour specimen of urine first on which an 11 -oxygenation index can be performed. Normal saline was given intravenously to correct the dehydration and to replace salt loss.
Cortisone, which replaces the deficiency of hydrocortisone and also suppresses excessive ACTH secretion by the anterior pituitary gland, was given. Large doses of 100 mg./day of hydrocortisone (in divided doses at six-hour intervals) were given intravenously or intramuscularly. After stabilization, cortisone was given by mouth in doses of about 50 mg./day, and this was then gradually reduced. The patients, before discharge from hospital, were receiving doses of cortisone varying from 15-37 5 mg./day, given in divided doses at six-hour intervals, though most were given either 25 or 15 mg./day. These were found to be the smallest doses of cortisone needed to correct the electrolyte disturbance and to keep the 1 7-ketosteroid levels down to normal limits for the patient's age. In addition, a salt-retaining hormone was used. Deoxycorticosterone acetate in oil (DCA) was given daily by intramuscular injection in doses varying from 2-5 mg./day. After stabilization, 9-x-fluorohydrocortisone in doses of 0 -1-0 -2 mg./day (given orally in two divided doses) was used instead. Six patients, however, were treated either with a long-acting DCA preparation given by intramuscular injection, or by implants of DCA pellets.
Oral administration of additional salt was also necessary. The patients were given 4 g. salt/day at first, and after stabilization, most were receiving 4-6 g./day. However, 6 patients required as little as 1-2 g./day, and 2 were receiving 8 g./day.
After discharge from hospital, patients were seen at fortnightly and then monthly intervals and later at two-monthly and then at three-monthly intervals. At each visit, weight and height were measured and these were plotted on a percentile chart, thus providing a follow-up of the developmental progress. In addition, urinary 17-ketosteroids and total 17-hydroxycorticoids were measured at six-monthly intervals, the 24-hour urine specimen being collected at home and sent by post. Bone age was estimated by radiography of the left wrist at six-monthly intervals. Steroid therapy was adjusted according to body height, bone age, and urinary 17-ketosteroid estimations, the aim being to keep these within normal limits wherever possible, and to give the smaLest dose of steroids necessary to achieve this.
Twelve of our patients have been followed to the age of 4 years. Of these, 9 were receiving cortisone in doses of 15-30 mg./day, 2 were receiving 37 5 mg./ day, and 1 needed 50 mg./day. Only 4 of the 12 patients still needed a salt-retaining hormone at this age. All were still maintained on added salt in doses of 1-4 g./day.
Of these 12 patients, 5 have reached the age of 8 years. The dose of cortisone required at this age was 50 mg./day in 2, and 37 5 mg. in 3. The saltretaining hormone had been stopped, but all were still having extra salt.
Complications of therapy were recorded in several cases. One child was given an implant of 500 mg. of DCA, at the age of 4 months: hypertension developed within a month, but the blood pressure returned to normal within 6 months. A second patient, who was maintained on 5 mg. of DCA daily by injection, at the age of 2 months (in 1953), developed hyperelectrolytaemia within a week. In 1955, 4 patients were treated with fluorodihydrocortisone alone (then a new drug). Two were not followed up because they left England. The other two died (see discussion of deaths). 9-x-fluorohydrocortisone (which differs from above) when given in suppressing doses of 1-2 mg./day has caused hypertension in 2 of our cases (Owen, Engel, and Wester, 1957 Simple Virilizig Type of Congenitl Adrenal Hyperplasia. Of the 29 patients in this category in our series, 13 were male and 16 were female. All boys with one exception presented at 5-7 years of age with the complaint that they were tall for their age. All had well-developed pubic hair, but no axillary or facial hair, or acne; the penis was large but the testes were normal and the bone age was advanced to the level of 13-14 years. There was an increase in the level of urinary 1 7-ketosteroids, 1 7-hydroxycorticoids, and pregnanetriol. Buccal smears were performed routinely and these confimed that all the patients were male. Serum electrolyte estimations were normal in all cases. In retrospect, the parents, in each case, stated that when the child was 21-3 years of age, they noticed that he was taller than other children, and that pubic hair had begun to appear. One patient was brought by his parents at the age of 24 years because he appeared tall. His bone age was then 91 years. By the age of 3 years, pubic hair was noticed.
The heights of all boys were above the 97th percentile when first seen, and were at the 50th percentile for a child of between 10 and 11 years. In all the boys, the initial 1 7-ketosteroid values varied between 10 and 40 mg./24 hr. In addition, 8 of these 13 patients showed large amounts of pregnanetriol, values varying between 10 and 30 mg./day The initial total 17-hydroxycorticoids were measured in three cases, the values being 41, 63, and 93 mg./24 hours respectively. RAITI AND NEWNS Laparotomy and testicular biopsy were performed on three boys in order to exclude tumours. Skull radiograph was normal in all patients. An ACTH and a cortisone suppression test were performed on 6 patients: the ACTH test showed no significant change in the 17-ketosteroid output in the urine, whereas cortisone caused a marked drop in the 17-ketosteroid levels and the disappearance of urinary pregnanetriol.
Eight boys were treated with cortisone by mouth in doses of 40 mg./day, and 3 were given doses of 50 mg./day. Two were treated with prednisolone 10 mg./day. All patients were maintained on this dose throughout except for 3 in whom the dose was increased to 75 mg. cortisone per day. The aim of treatment has been to lower the production of androgenic substances (as measured by urinary 17-ketosteroid excretion) to normal limits for age and hence to slow down the rapid rate of bone growth and development.
One patient fractured the midshaft of his left ulna at the age of 7 years. He had been receiving steroids for 6 months. By the age of 9 years, the fracture was still not united. Steroid therapy was then stopped, in an attempt to facilitate healing of the fracture.
One boy died. Six months after commencing treatment with steroids he developed symptoms and signs of rheumatoid arthritis. The dose of cortisone was increased to 300 mg./day and subsequently reduced gradually to 62-5 mg./day. There was a remission followed by a relapse three months later, during which he died. At necropsy, the diagnoses of congenital adrenal hyperplasia and of rheumatoid arthritis were confirmed. In addition, there was evidence of pericarditis and pleurisy, the clinical signs of which were present before death.
In the affected girls, the age ofpresentation differed from that of the boys, as they were referred because of abnormal genitalia. Of 16 girls, 9 were first seen before they were 2 months old, 4 presented at about 4 years, and the other 3 presented at 7 years, 71 years, and 9 years, respectively. The serum electrolytes were normal. The 17-ketosteroid values were raised, the levels varying between 2-5 and 30 mg./24 hr. Pregnanetriol was found in the urine of those in whom it was estimated. Seven girls were treated with prednisolone, the dose varying from 2-5 to 10 mg./day. The remaining girls were treated with cortisone, the dose varying from 25 to 50 mg./ day. Because of the earlier age of presentation and initiation of treatment, the heights of these patients were maintained at about the 50th percentile for age and sex.
One girl was born with a hare-lip and cleft palate.
Another patient was mentally retarded. There were no deaths in this group.
Hypertensive Type of Congenital Adrenal Hyperplsima We have only one patient who belongs to this group. He was born in 1946, and at birth he was thought to be a male. In 1949, plastic surgery for hypospadias was performed. He was then lost to follow-up, and was not seen again until 1957, i.e. when II years old. It was then noticed that he had hypertension. His buccal smear showed that his sex was female. His height was on the 97th percentile and his blood pressure was 200/140 mm. Hg. Pubic and axillary hair were present. His 1 7-ketosteroid level was 30 mg./24 hr. and compound 'S' was found in excessive amounts in his urine.
Following treatment with cortisone 50 mg./day, there was some fall in blood pressure. Later reserpine was added. Soon after cortisone therapy was commenced, he began to menstruate and so his ovaries were irradiated in order to stop menstruation. Urine should be collected for 17-ketosteroid, total 1 7-hydroxycorticoid, and pregnanetriol estimations. Two-dimensional paper chromatographic study of the steroid excretion pattern should be undertaken, since it is known that some cases of congenital adrenal hyperplasia may have a normal 17-ketosteroid output during the early weeks of life. With chromatography one can detect the presence and type of abnormal metabolites. The determination ofthe I I -oxygenation index is also a useful procedure. It is particularly suitable for those patients from whom only a 4-or 5-hour urine specimen can be obtained because they are dehydrated and require urgent treatment.
After initial stabilization most of our patients have been treated with oral preparations. Cortisone is used because it has greater salt-retaining effects than does prednisolone. 9-x-fluorohydrocortisone has proved to be a useful salt-retaining hormone when used in smaller doses of 0-05 to 0*2 mg./day. Added salt of the order of4 g. per day is also required.
It is interesting to note that only 4 of 12 patients were receiving a mineralocorticoid at the age of 4 years and that none of the 5 patients followed to 8 years of age or more were receiving any salt-retaining hormone. It seems that after 4-5 years of age, added salt-retaining hormone is not necessary. Oral steroids are preferred to long-acting DCA depot preparations.
Triamcinolone has not been used in our series but has been used in the U.S.A. Its side-effects include muscle weakness, hirsutes, psychosis, and papilloedema (Dees and McKay, 1959) . Long-acting preparations such as hydrocortisone acetate (Litman and Donnell, 1960) and prednisolone trimethylacetate (Dingman, Maranan, and Staub, 1962) Table 5 . Diagnostic and follow-up procedures are summarized in Table 7 .
Surgical procedures on girls are now performed at the age of 18 months to 2 years when there has been adequate stabilization and control. At the same time a plastic operation is performed on the vagina.
A considerable amount of study has been devoted to determining the cause for salt loss. Eberlein (1958) has pointed out that these patients differ from those with Addisons disease in that more saltretaining hormone is required for treatment of children with congenital adrenal hyperplasia than is needed for adults with Addison's disease. Bongiovanni and Eberlein (1958) showed that a severer degree of defect in the production of cortisol occurred in patients with the salt-losing type of the disorder than in patients with the simple virilizing type and suggested that this might be related to the severity of the enzyme defect. Bongiovanni also postulated that there might be a salt-losing factor produced by the adrenals in most patients with congenital adrenal hyperplasia, but that compensation occurred if aldosterone production could be increased. Blizzard et al. (1959) have shown that patients with the virilizing type can respond to a lowsalt diet by increasing their aldosterone excretion, but that patients with the salt-losing type excrete deficient amounts of aldosterone as compared with normal subjects and that they are unable to respond to a low-salt diet with any significant increase in aldosterone excretion. Bryan, Kliman, and Bartter (1962) have demonstrated evidence for impaired aldosterone production in the salt-losing type.
The same enzyme, 21-hydroxylase, is required in the pathway for formation both of hydrocortisone and of the salt-retaining hormones, corticosterone and aldosterone. No added salt-retaining hormone is needed after 4-5 years of age, and so it is possible that either there is partial recovery of this enzyme system or that an alternative metabolic pathway is developed to allow production of sufficient saltretaining hormone.
We draw attention to the observation that infants with the salt-losing type of congenital adrenal hyperplasia require 15-37 5 mg. cortisone per day for treatment. This is five to ten times the normal hydrocortisone production rate as measured by Kenny et al. (1963) . It may be assumed that a proportion of the drug is not absorbed. However, adults either with Addison's disease or who have had total adrenalectomy usually only require I' -5-50 mg./day of cortisone for replacement therapy, i.e. the equivalent of, or only double, the normal hydrocortisone production rate for an adult. It appears that cortisone is needed not only for replacement but also for its suppressive effect on -ACTH and androgen production.
In the simple virilizing type of the disorder, the female presents early, usually during the first or second month of life because the abnormal genitalia are so easily recognized. If Treatment is continued beyond puberty in order to allow fertility, since excessive androgenic production will suppress gonadotrophic activity. Moreover, these patients have defective production of hydrocortisone and therefore require glucocorticoid replacement therapy. They are unable to respond normally during such stresses as acute infections or surgey, and therefore require increased doses of steroids. If this need is not met, they will undergo an Addisonian crisis which will resemble the saltlosing type of the disorder, and they will require treatment on the same lines as previously indicated.
Occasionally, an adrenal adenoma may present with clinical features similar to those of simple virilizing type of congenital adrenal hyperplasia. A cortisone suppression or preferably a dexamethasone suppression test is carried out. If the patient has an adenoma, there will be no fall in the output of 17-ketosteroids and total 17-hydroxycorticoids. But in patients with congenital adrenal hyperplasia who present at 5 or 6 years of age, cortisone in doses of 100 mg./day, or its equivalent, may have to be given for several weeks or even a month, before the urinary 1 7-ketosteroids can be suppressed to normal levels.
Before the introduction of steroid therapy at the beginning of the last decade it was generally felt that, because these children have so many masculine features they should be brought up as males (Wilkins, 1957) . Adequate suppression therapy is now available, and the females now can and should be reared as girls. In cases where a mistake in the sex is made (which occurs more rarely now), and the child is reared as a boy, change of sex should not be contemplated after 2 years of age (Money, Hampson, and Hampson, 1955) . Such children develop a normal male sex orientation. Several of the children required psychotherapy. This was more often needed for girls of4 to 5 years of age who still had an enlarged clitoris. These children had noticed that they were different from other girls of their age and that their genitals resembled those of their male playmates. Boys with the simple virilizing type of congenital adrenal hyperplasia and who were not diagnosed until 5 to 7 years of age also had psychological difficulties. 
